Registry for MAASTRO rectal applicator treatment
Part of Cancer, Digestive system clinical trials.
This study collects data from people treated with a special rectal applicator for rectal cancer. The goal is to observe long-term outcomes and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rectal cancer (or very strong suspicion based on imaging).
- Your treatment involves the MAASTRO HDR rectal applicator.
- You agree to have your medical data collected for research over time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special device (Maastro applicator) that delivers radiation directly to rectal tumors from inside the rectum. It is for people with rectal cancer who can have this type of internal radiation therapy.
This study looks at adults with rectal cancer that hasn't spread, to learn more about the disease and treatments. It includes people who get a special treatment before surgery (TNT) or who have a specific genetic type of rectal cancer (dMMR/MSI-H).
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
This trial tests a new approach for people with locally advanced rectal cancer that has high-risk features. It combines short-course radiation with chemotherapy (CapeOX) and the immunotherapy drug toripalimab, with or without another drug called surufatinib, before surgery. The goal is to see if adding these drugs helps shrink the tumor and improve outcomes.
This trial analyzes biological and clinical information from people who have had surgery for rectal cancer since 2019. It aims to better understand rectal tumors, which may help improve future treatments.
This study asks people with rectal cancer to share their experiences in clinical trials. It may help researchers understand what patients go through, and could improve how future rectal cancer studies are designed.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.